Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04637 (
p53
)
77,613
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The creatine kinases (CK) regenerate
ATP
for cellular reactions with a high energy expenditure. While muscle CK (CKM) is expressed almost exclusively in adult skeletal and cardiac muscle, brain CK (CKB) expression is more widespread and is highest in brain glial cells. CKB expression is also high in human lung tumor cells, many of which contain mutations in
p53
alleles. We have recently detected high levels of CKB mRNA in HeLa cells and, in this study, have tested whether this may be due to the extremely low amounts of
p53 protein
present in HeLa cells. Transient transfection experiments showed that wild-type mouse
p53
severely repressed the rat CKB promoter in HeLa but not CV-1 monkey kidney cells, suggesting that, in HeLa but not CV-1 cells,
p53
either associates with a required corepressor or undergoes a posttranslational modification necessary for CKB repression. Conversely, mouse wild-type
p53
strongly activated the rat CKM promoter in CV-1 cells but not in HeLa cells, suggesting that, in CV-1 cells,
p53
may associate with a required coactivator or is modified in a manner necessary for CKM activation. The DNA sequences required for
p53
-mediated modulations were found to be within bp -195 to +5 of the CKB promoter and within bp -168 to -97 of the CKM promoter. Moreover, a 112-bp fragment from the proximal rat CKM promoter (bp -168 to -57), which contained five degenerate
p53
-binding elements, was capable of conferring
p53
-mediated activation on a heterologous promoter in CV-1 cells. Also, this novel
p53
sequence, when situated in the native 168-bp rat CKM promoter, conferred
p53
-mediated activation equal to or greater than that of the originally characterized far-upstream (bp -3160) mouse CKM
p53
element. Therefore, CKB and CKM may be among the few cellular genes which could be targets of
p53
in vivo. In addition, we analyzed a series of missense mutants with alterations in conserved region II of
p53
. Mutations affected
p53
transrepression and transactivation activities differently, indicating that these activities in
p53
are separable. The ability of
p53
mutants to transactivate correlated well with their ability to inhibit transformation of rat embryonic fibroblasts by adenovirus E1a and activated Ras.
...
PMID:Mouse p53 represses the rat brain creatine kinase gene but activates the rat muscle creatine kinase gene. 796 81
Rodent embryo cells immortalized with temperature-sensitive mutants of simian virus 40 large tumor (T) antigen have a proliferative potential that depends on temperature. At the restrictive temperature, heat-inactivation of large T antigen causes
p53
release, growth arrest, and cell death. Morphological and molecular analysis indicate that the induced cell death corresponds to apoptosis. Flow cytometric analysis using a combination of forward light scatter and side scatter allows a discrimination of cells committed to apoptosis within the whole population. These cells display a reduction in cell size and a higher cellular density, confirming the apoptotic nature of the cell death. When cells exhibiting the morphological features of apoptosis were stained with a fluorescent probe of the mitochondrial membrane potential, a decreased accumulation of the dye was recorded. Measures of cellular respiration, performed with whole-cell populations, showed that the lower mitochondrial membrane potential (delta psi m) correlates, as expected, with an uncoupling of electron transport from
ATP
production and is linked to the induction of apoptosis. We also show that this decrease in delta psi m is associated with a decrease in the rate of mitochondrial translation. These events are detected at early stages of the apoptotic process, when most of the cells are not irreversibly committed to death, suggesting that mitochondria could be a primary target during apoptosis.
...
PMID:Commitment to apoptosis is associated with changes in mitochondrial biogenesis and activity in cell lines conditionally immortalized with simian virus 40. 797 36
The wild-type
tumor suppressor protein p53
is a short-lived protein that plays important roles in regulation of cell cycle, differentiation, and survival. Mutations that inactivate or alter the tumor suppressor activity of the protein seem to be the most common genetic change in human cancer and are frequently associated with changes in its stability. The ubiquitin system has been implicated in the degradation of
p53
both in vivo and in vitro. A mutant cell line that harbors a thermolabile ubiquitin-activating enzyme, E1, fails to degrade
p53
at the nonpermissive temperature. Studies in cell-free extracts have shown that covalent attachment of ubiquitin to the protein requires the three conjugating enzymes: E1, a novel species of ubiquitin-carrier protein (ubiquitin-conjugating enzyme; UBC),E2-F1, and an ubiquitin-protein ligase, E3. Recognition of
p53
by the ligase is facilitated by formation of a complex between the protein and the human papillomavirus (HPV) oncoprotein E6. Therefore, the ligase has been designated E6-associated protein (E6-AP). However, these in vitro studies have not demonstrated that the conjugates serve as essential intermediates in the proteolytic process. In fact, in many cases, conjugation of ubiquitin to the target protein does not signal its degradation. Thus, it is essential to demonstrate that
p53
-ubiquitin adducts serve as essential proteolytic intermediates and are recognized and degraded by the 26S protease complex, the proteolytic arm of the ubiquitin pathway. In this study, we demonstrate that conjugates of
p53
generated in the presence of purified, E1, E2, E6-AP, E6, ubiquitin and
ATP
, are specifically recognized by the 26S protease complex and degraded. In contrast, unconjugated
p53
remains stable. The ability to reconstitute the system from purified components will enable detailed analysis of the recognition process and the structural motifs involved in targeting the protein for degradation.
...
PMID:Complete reconstitution of conjugation and subsequent degradation of the tumor suppressor protein p53 by purified components of the ubiquitin proteolytic system. 803 27
Almost all atypical epithelial lesions of the stomach consist of atypical cells in the superficial part of the glands and nonatypical cells in the deeper portion of the glands. A transition zone was formed between the superficial atypical gland cells and the deeper nonatypical gland cells. Positive cells were widely demonstrated with immunohistochemical stains for PCNA in the superficial atypical glands and transition zone. The rate of PCNA positivity was 37.7%. However, a small number of positive cells for EGFR (8.5%), c-erbB-2(11.3%),
p53
(11.3%) and c-K-ras(1.7%) were found in
ATP
. The incidence of positivity for these factors was low compared with that for carcinomas. The percentages of positive cells for EGFR(1.5%) and c-erbB-2(4.5%) were very low in intestinal metaplasia.
...
PMID:[Immunohistochemical study for growth factor and oncogene on atypical epithelium of the stomach]. 810 26
p53
is the most frequent known target for mutation in human cancer. Evidence suggests that
p53 protein
may be involved variously in transcription and cell cycle control, in DNA replication and in G1 checkpoint control following the cellular response to radiation induced DNA damage.
p53
blocks DNA replication of the small DNA tumour virus, simian virus 40, by inhibiting unwinding of the viral origin of replication by the DNA helicase activity of the virally encoded large T antigen protein. Here we report the novel observation that human
p53 protein
can bind
ATP
and exhibits an intrinsic
ATP
stimulated DNA strand reassociation activity. Both activities map to the carboxyl terminal 128 amino acids of
p53
. Thus, in addition to any role in transcription, our results indicate that
p53
is potentially capable of inhibiting mammalian replicative DNA synthesis by blocking the DNA strand separation step during replication origin recruitment. However, the ability of
p53
to modulate the topological relationship between complementary nucleotide strands is also compatible with a direct role for
p53
in other aspects of DNA synthesis, recombination or repair.
...
PMID:Human p53 directs DNA strand reassociation and is photolabelled by 8-azido ATP. 818 76
SV40 large T-antigen (T-ag) mutants were generated using a cassette mutagenesis strategy and naturally occurring restriction sites. T-ag mutant constructs included internal in-frame deletions, frame-shift deletions that resulted in amino-terminal fragments, and internal initiation mutants that produced carboxy-terminal fragments; no foreign amino acids were introduced. The deletion mutants were stably expressed in BALB/c 3T3E cells and were analyzed for ability to bind heat shock cognate protein 70 using an
ATP
release assay of T-ag immunoprecipitates. Complex formation between heat shock protein and T-ag was independent of
p53
involvement. The heat shock protein binding domain was narrowed to the amino-terminal 97 amino acids of T-ag, with the first 29 residues influencing the interaction. The amino-terminal domain of T-ag is important in both viral replication and cell transformation. We propose that the functional interactions of this highly interactive region of T-ag may be modulated by heat shock cognate protein 70.
...
PMID:Construction of SV40 deletion mutants and delimitation of the binding domain for heat shock protein to the amino terminus of large T-antigen. 819 89
It has been demonstrated that
p53
, especially, mutant p53 (mp53), makes protein complexes with major heat shock proteins hsp72/hsc73. However, there is no direct evidence showing whether hsp72 or hsc73 could bind preferentially to
p53
. In the present study, using TYKnu human ovarial carcinoma cells and monoclonal antibodies reacting specifically to hsp72/hsc73, we were able to find the selective protein complex formation with
p53
, presumably mp53, and hsc73, but not in the case of
p53
and hsp72. The
p53
-hsc73 protein complexes dissociate with the addition of
ATP
, indicating that the dissociation is dependent upon the
ATP
-hydrolysis. These data suggest that hsc73 rather than hsp72 plays an important role in the yet undefined mechanism of disregulated cell growth control by mp53.
...
PMID:Demonstration of selective protein complexes of p53 with 73 kDa heat shock cognate protein, but not with 72 kDa heat shock protein in human tumor cells. 822 31
To more precisely map the immortalization and
p53
binding domains of T antigen, a large series of overlapping deletion mutations were created between codons 251 to 651 by utilizing a combination of Bal 31 deletion and oligonucleotide-directed mutagenesis. Immortalization assay results indicated that amino acids (aa) 252 to 350, 400, and 451 to 532 could be removed without seriously compromising immortalization, although the appearance of immortal colonies was delayed in some cases. Western immunoblotting experiments indicated that the
p53
binding capacities of T antigen produced by mutants missing aa 252 to 300, 301 to 350, 400, or 451 to 532 were only slightly reduced relative to that of wild-type T antigen. Within the limits of this deletion analysis, the immortalization and
p53
binding domains appear to be colinear and, in fact, may represent two aspects of the same domain. This deletion analysis eliminates the entire zinc finger domain (aa 302 to 320), a small portion of the leucine-rich region (aa 345 to 350), and a large portion of the
ATP
binding domain (aa 451 to 528) as participants in
p53
binding or in the immortalization process. The results also show that removal of T antigen amino acids within the region 451 to 532 appears to alter the capacity of newly synthesized but not older T antigen and
p53
molecules to form complexes.
...
PMID:Association of p53 binding and immortalization of primary C57BL/6 mouse embryo fibroblasts by using simian virus 40 T-antigen mutants bearing internal overlapping deletion mutations. 838 12
Both the tumor suppressor gene products, the retinoblastoma sensitivity gene product pRb110 and
p53
, are found in oligomer complexes with the oncogene products of the DNA tumor viruses. It has been demonstrated that
p53
binds to the M(r) 70,000 heat shock protein family. However, the protein association of pRb110 with the M(r) 70,000 heat shock protein family is not yet known. We analyzed the immunoprecipitates made with TYK-nu human ovarial carcinoma cell lysate and anti-pRb110 or anti-heat shock protein monoclonal antibodies. In this paper, we demonstrate that pRb110 is associated with the M(r) 73,000 heat shock cognate protein, but not with the M(r) 72,000 heat shock protein. This selective protein association was also detected in HeLa cervical carcinoma cells. Furthermore, the protein complexes of the M(r) 73,000 heat shock cognate protein and pRb110 were dissociated with the presence of
ATP
, but not with ADP and the nonhydrolyzable
ATP
analogue,
ATP
gamma S. This indicates that the dissociation is dependent on the
ATP
hydrolysis. These data may suggest an as yet undefined important role of M(r) 73,000 heat shock cognate protein in the cell growth control in collaboration with pRb110.
...
PMID:Protein interaction of retinoblastoma gene product pRb110 with M(r) 73,000 heat shock cognate protein. 845 45
The
p53 tumor suppressor
gene product is a sequence-specific DNA-binding protein that is necessary for the G1 arrest of many cell types. Consistent with its role as a cell cycle checkpoint factor,
p53
has been shown to be capable of both transcriptional activation and repression. Here we show a new potential role for
p53
as a DNA-binding-dependent regulator of DNA replication. Constructs containing multiple copies of the ribosomal gene cluster (RGC)
p53
binding site cloned on the late side of the polyomavirus origin were used in in vitro replication assays. In the presence of
p53
, the replication of these constructs was strongly inhibited, while the replication of constructs containing a mutant version of the RGC site was not affected by
p53
. Several tumor-derived mutant p53 proteins were unable to inhibit replication of the construct with wild-type RGC sites. Additionally, the transactivator GAL4-VP16 was unable to inhibit replication of a construct containing GAL4 binding sites adjacent to the polyomavirus origin. We also show that the inhibition by
p53
can occur from sites cloned as far as 600 bp from the origin. Preincubation experiments suggest that
p53
inhibits replication at a step mediated by
ATP
, possibly by inhibiting the binding of polyomavirus T antigen to the core origin. The presence of an endogenous
p53
binding site in the polyomavirus origin suggests potential mechanisms for the observed inhibition.
...
PMID:p53 inhibits DNA replication in vitro in a DNA-binding-dependent manner. 852 20
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>